Real-time Reminders To Decrease Late or Missed Meal Boluses
Klue
Pilot Study to Test Efficacy of Real-time Reminders on Apple Watch To Decrease Late or Missed Meal Boluses
1 other identifier
interventional
24
1 country
1
Brief Summary
This study is examining whether the Klue app is effective in detecting missed or late meal boluses in patients with Type 1 diabetes. The app is programmed onto an Apple Watch and will detect potential missed boluses from hand motion. It will send text alerts to the user asking if they have bolused. This is a pilot study and will assess whether there is a change in the number of missed meal boluses in the two weeks prior to each visit. If the findings are significant, this software can be integrated in future closed-loop algorithms for automatic insulin delivery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 23, 2018
CompletedStudy Start
First participant enrolled
October 12, 2018
CompletedFirst Posted
Study publicly available on registry
June 3, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 19, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2020
CompletedSeptember 2, 2021
August 1, 2021
1.4 years
August 23, 2018
August 31, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Change in the number of missed meal boluses
A missed meal bolus is defined by no insulin dose within 2 hours from the start of the CGM rise.
The two weeks prior to each study visit
Secondary Outcomes (2)
Change in time in range
data for 1 month prior to each study visit at baseline, 6 weeks and 12 weeks of this 12 week study for each subject
Positive predictive value of a Klue meal alert
All data for the 6 weeks on the Klue intervention arm when Klue is active
Study Arms (2)
Standard Care
NO INTERVENTIONParticipants will be in their usual care, wearing a continuous glucose sensor and taking insulin by pump or by pens with memory
Klue
EXPERIMENTALSubjects will wear an Apple watch on their dominant hand and receive alerts when eating behavior is detected by the Klue software.
Interventions
Klue is a software program the uses an Apple watch to detect hand motions which are indicative of eating.
Eligibility Criteria
You may qualify if:
- Age 13 and over
- On an insulin pump for at least 3 months and using CGM or using an insulin pen with memory and a CGM
- Willing to wear a CGM at least 70% of the time while in the study
- Using an iPhone
- Willing to wear an Apple watch on their dominant hand while awake
- Missing or late in giving at least four food boluses in the previous two weeks
- Understanding and willingness to follow the protocol and sign informed consent
- Ability to speak, read and write in the language of the investigators
You may not qualify if:
- Pregnant or lactating
- A known medical condition that in the judgment of the investigator might interfere with the completion of the protocol
- Current treatment for a seizure disorder
- Inpatient psychiatric treatment in the past 6 months
- Note: Adequately treated thyroid disease and celiac disease do not exclude subjects from enrollment. They may be participating in another trial, if this study is approved by the investigators of the other trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford
Palo Alto, California, 94305, United States
Related Publications (2)
Burdick J, Chase HP, Slover RH, Knievel K, Scrimgeour L, Maniatis AK, Klingensmith GJ. Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy. Pediatrics. 2004 Mar;113(3 Pt 1):e221-4. doi: 10.1542/peds.113.3.e221.
PMID: 14993580BACKGROUNDOlinder AL, Kernell A, Smide B. Missed bolus doses: devastating for metabolic control in CSII-treated adolescents with type 1 diabetes. Pediatr Diabetes. 2009 Apr;10(2):142-8. doi: 10.1111/j.1399-5448.2008.00462.x. Epub 2008 Oct 24.
PMID: 19175898BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Bruce Buckingham, MD
Stanford University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Pediatric Endocrinology
Study Record Dates
First Submitted
August 23, 2018
First Posted
June 3, 2019
Study Start
October 12, 2018
Primary Completion
March 19, 2020
Study Completion
March 30, 2020
Last Updated
September 2, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share